Follow Us:
Tuesday, April 07, 2020

National Pharmaceutical Pricing Authority

NATIONAL PHARMACEUTICAL PRICING AUTHORITY NEWS

Provide information on masks, hand sanitisers by end of day: NPPA to manufacturers

March 18, 2020 4:51 pm

Last week, NPPA directed all manufacturers and importers of surgical and protective masks, gloves and hand sanitisers to furnish information on these items by March 17, 2020.

NPPA allows firms to hike prices of knee implants by up to 10 per cent

August 14, 2019 3:30 am

The development comes around two years after the regulator first slashed MRPs of knee implants by up to 69 per cent, using extraordinary powers granted under the country’s drug pricing regulations.

Misreading the pharma market

July 10, 2018 6:50 am

The DPCO 2013 covers only 376 essential medicines in specific presentations and strengths. India’s domestic pharma market sales is about Rs 1.3 lakh crore per year. Perfect competition does not favour the patient.

No easy cures

July 02, 2018 12:06 am

Drug regulator’s decision to revise last year's ceiling on paediatric drug underlines price controls can be counterproductive.

Despite no cap ‘indication’, govt put knee implant under price limit

June 16, 2018 2:24 pm

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

Sans consultant since November, NPPA faces multiple legal hurdles

June 05, 2018 2:57 am

According to the information gathered by The Indian Express, at least 26 cases have been filed post November 30, 2017, and high courts have given relief to the firms in most of the cases by granting stay orders against any “coercive action” by NPPA.

Complaints with NPPA about drug shortage up 6-fold in 2017-18

May 17, 2018 2:05 am

According to the data of pricing regulator, the number of complaints filed regarding shortage of medicines were just 7 in 2016-17. This figure saw a jump to 42 in 2017-18.

Unbranded generics, ‘orphan drugs’ may go out of price control

May 03, 2018 2:55 am

Drugs for rare diseases are usually very expensive as pharma firms do not find it viable to sell such medicines.

Drug pricing: A regulatory tug of war

February 27, 2018 1:11 am

At a recent meeting, NPPA suggested that govt abandon the ‘archaic practice’ of reviewing its decisions despite pharma players seeking greater intervention.

Denied once, NPPA begins work on new drug price control list

October 18, 2014 10:34 am

Opens consultations with stakeholders, pharmaceutical industry voice opposition.